Choroid thickness profile in patients with lupus nephritis
Autor: | L Ribeiro, D Rodrigues, R Rothwell, S Fonseca, M Oliveira, J Braga, R Varandas |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Pathology medicine.medical_specialty Prednisolone Lupus nephritis 03 medical and health sciences 0302 clinical medicine Rheumatology medicine Humans In patient 030203 arthritis & rheumatology Analysis of Variance Kidney Choroid business.industry Middle Aged medicine.disease Lupus Nephritis eye diseases Cross-Sectional Studies medicine.anatomical_structure Case-Control Studies 030221 ophthalmology & optometry Female sense organs business Tomography Optical Coherence Hydroxychloroquine |
Zdroj: | Lupus. 28:475-482 |
ISSN: | 1477-0962 0961-2033 |
DOI: | 10.1177/0961203319828525 |
Popis: | BackgroundChoroidopathy is a rare manifestation of systemic lupus erythematosus (SLE). This entity is associated with active phases of severe SLE and it is frequently accompanied by acute kidney failure, central nervous system involvement and coagulopathy.PurposeTo evaluate the choroid thickness of patients with lupus nephritis (LN) without choroidopathy, and to compare this with that of age-matched SLE patients without LN and healthy control subjects.Study designCross-sectional case control study.Material and methodsFifteen women with LN in remission phase (study group), 15 women with SLE in remission without LN (SLE control group), and 15 healthy women (healthy control group), without ocular diseases or significant refractive error, were recruited. Full ophthalmological examination and a macular optical coherence tomography in enhanced depth imaging mode were performed. The choroid thickness was measured at nine macular points and six lines of mean choroidal thickness were determined. A comparative analysis between the three groups was performed using the one-way ANOVA test and the paired t-test. The choroid thickness of patients under corticotherapy was also compared to that of patients without corticotherapy. Additionally, the correlation between choroid thickness and disease duration was evaluated using the Pearson analysis.ResultsThe mean macular choroidal thickness was 295.73 ± 67.62 μm in the study group, 233.34 ± 41.01 µm in the SLE control group, and 240.98 ± 37.93 μm in the control group ( p = 0.00006 and p = 0.0003, respectively). Additionally, the choroid thickness was significantly thicker than in the SLE and healthy control groups at the foveal ( p = 0.004 and p ConclusionThis study suggests a relationship between LN and choroidal changes, which may represent an increased risk for choroidopathy in these patients. Choroid thickening was not related with the duration of the disease. This thickening may be correlated with histopathological changes similar to those occurring in kidney glomeruli. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |